Conversion of the CPT-11 metabolite APC to SN-38 by rabbit liver carboxylesterase.

The anticancer drug CPT-11 (7-ethyl-[4(1-piperidino)-1-piperidino]carbonyloxycamptothecin) is a water-soluble derivative of camptothecin. We report here the conversion of APC (7-ethyl-[4-N-(5-aminopentanoic acid)-1-piperidino] carbonyloxycamptothecin), an inactive metabolite of CPT-11, to SN-38 (7-ethyl-10-hydroxycamptothecin), the active metabolite of CPT-11, by a rabbit liver carboxylesterase. This reaction is not catalyzed by any known human enzyme. The formation of SN-38 from APC was characterized by an apparent Km of 37.9 +/- 7.1 microM and a Vmax of 16.9 +/- 0.9 pmol/units/min. SN-38 was confirmed as a reaction product by high-performance liquid chromatography and mass spectrometry. A 24-h incubation of 10 microM APC with 500 units/ml of rabbit carboxylesterase produced 4 microM SN-38. The product of this reaction inhibited the growth of U373 MG human glioblastoma cells in vitro. The IC50 for a 24-h exposure of U373 MG cells to APC in the presence of 50 units/ml of rabbit carboxylesterase was 0.27 +/- 0.08 microM, whereas APC alone demonstrated no inhibition of growth at concentrations up to 1 microM. The IC50 of U373 MG cells transfected with the cDNA encoding the rabbit carboxylesterase (U373pIRESrabbit) and exposed to APC for 24 h was 0.8 +/- 0.1 microM APC, whereas the growth of cells transfected with vector control (U373pIRES) was unaffected by up to 1 microM APC. Because APC is nontoxic to human cells, we are investigating the possibility of using APC/rabbit carboxylesterase in a prodrug/enzyme therapeutic approach.

[1]  C. Morton,et al.  Isolation and partial characterization of a cDNA encoding a rabbit liver carboxylesterase that activates the prodrug irinotecan (CPT-11). , 1998, Cancer research.

[2]  R. Crystal,et al.  In vivo human carboxylesterase cDNA gene transfer to activate the prodrug CPT-11 for local treatment of solid tumors. , 1998, The Journal of clinical investigation.

[3]  J. Robert,et al.  Metabolism of irinotecan (CPT-11) by human hepatic microsomes: participation of cytochrome P-450 3A and drug interactions. , 1998, Cancer research.

[4]  C. Morton,et al.  Overexpression of a rabbit liver carboxylesterase sensitizes human tumor cells to CPT-11. , 1998, Cancer research.

[5]  G. Chabot.  Clinical Pharmacokinetics of Irinotecan , 1997, Clinical pharmacokinetics.

[6]  J. Armand,et al.  Pharmacokinetic interrelationships of irinotecan (CPT-11) and its three major plasma metabolites in patients enrolled in phase I/II trials. , 1997, Clinical cancer research : an official journal of the American Association for Cancer Research.

[7]  C. Naus,et al.  Gap junctions promote the bystander effect of herpes simplex virus thymidine kinase in vivo. , 1997, Cancer research.

[8]  F. Lokiec,et al.  Irinotecan (CPT-11) metabolites in human bile and urine. , 1996, Clinical cancer research : an official journal of the American Association for Cancer Research.

[9]  J. Robert,et al.  Conversion of irinotecan (CPT-11) to its active metabolite, 7-ethyl-10-hydroxycamptothecin (SN-38), by human liver carboxylesterase. , 1996, Biochemical pharmacology.

[10]  J. Robert,et al.  Identification and properties of a major plasma metabolite of irinotecan (CPT-11) isolated from the plasma of patients. , 1996, Cancer research.

[11]  J. Robert,et al.  Reversed-phase high-performance liquid chromatographic method for the simultaneous quantitation of the carboxylate and lactone forms of the camptothecin derivative irinotecan, CPT-11, and its metabolite SN-38 in plasma. , 1994, Journal of chromatography. B, Biomedical applications.

[12]  P. Hérait,et al.  CPT-11-induced cholinergic effects in cancer patients. , 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[13]  R. Martuza,et al.  Gene therapy of maliganant brain tumors: A rat glioma line bearing the herpes simplex virus type 1‐thymidine kinase gene and wild type retrovirus kills other tumor cells , 1992, Journal of neuroscience research.

[14]  T. Yoshimoto,et al.  CPT-11 converting enzyme from rat serum: purification and some properties. , 1991, Journal of pharmacobio-dynamics.

[15]  D. Hui,et al.  Identification of the active site serine in pancreatic cholesterol esterase by chemical modification and site-specific mutagenesis. , 1990, The Journal of biological chemistry.

[16]  M Hosokawa,et al.  Characterization of molecular species of liver microsomal carboxylesterases of several animal species and humans. , 1990, Archives of biochemistry and biophysics.

[17]  R. Mentlein,et al.  Hydrolysis of ester- and amide-type drugs by the purified isoenzymes of nonspecific carboxylesterase from rat liver. , 1984, Biochemical pharmacology.